PRESS RELEASE: Proposed Landmark Settlement Re: Treatment of Chronic Hepatitis C
November 19, 2018 | PA Institutional Law Project and David Rudovsky, Esq.
PRESS RELEASE
FOR IMMEDIATE RELEASE
PROPOSED LANDMARK SETTLEMENT ON ACCESS TO MEDICAL TREATMENT WOULD PROVIDE HIGHLY EFFECTIVE MEDICAL TREATMENT FOR PRISONERS WITH CHRONIC HEPATITIS C IN THE PENNSYLVANIA DOC
Contacts:
David Rudovsky, Esq.: 215-925-4400, drudovsky@klrawphila.com
Su Ming Yeh, Esq. (PA Institutional Law Project): 215-925-2966, smyeh@pailp.org
Philadelphia, PA, November 19, 2018:
Plaintiffs’ counsel announced a proposed landmark settlement in a class action lawsuit against the Pennsylvania Department of Corrections that would provide much-needed medical treatment for thousands of prisoners with Chronic Hepatitis C.
“Chronic Hepatitis C is the most lethal of all viral illnesses in the United States. In its early stages, it can cause painful and debilitating conditions of fatigue; muscle, joint, and bone pain; and depression. Left untreated, the virus will eventually cause liver failure, high risks of liver cancer, and death. ‘The new DAA treatment is highly effective in curing the disease with a simple regimen of pills and without serious side effects,’ explained Su Ming Yeh, Deputy Director of the Pennsylvania Institutional Law Project. ‘The health of thousands of prisoners will be improved now that they will have access to this potentially life-saving medication.’”